44.6
Achieve Life Sciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
27.3
FY23:
17.0
FY24:
36.5
FY25:
39.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.92
FY22:
2.64
FY23:
2.39
FY24:
2.17
FY25:
1.90
Total assets
Change from FY21 to FY25
millions USD
FY21:
47.5
FY22:
30.0
FY23:
19.4
FY24:
38.6
FY25:
41.8
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.55
FY22:
21.6
FY23:
20.8
FY24:
6.68
FY25:
9.08
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.9
FY22:
0.07
FY23:
0.01
FY24:
11.1
FY25:
11.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
28.0
FY22:
8.30
FY23:
−1.45
FY24:
20.9
FY25:
21.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
47.5
FY22:
30.0
FY23:
19.4
FY24:
38.6
FY25:
41.8
All amounts in millions USD